Inhibition of c-Met downregulates TIGAR expression and reduces NADPH production leading to cell death
暂无分享,去创建一个
G. Mills | S. Tsui | T. Mok | S. Tsao | S. Cheng | P. Ng | C. Tsang | M. Ng | A. Chan | K. Lo | E. Wong | C. Lau | G. Mills | C. Tsang | B. Hong | C. Lau | S. Tsao | S. Cheng | Emily Y M Lam | T. Mok | K. Ho | S. Tsui | Yuen-Keng Ng | M. Ng | A. Chan | V. Lui | E. Wong | C. Lau | E. Lam | P. Ng | Y-K Ng | Sh Cheng | Tsk Mok | M. Ng | V. Lui | Y. K. Ng | V. Lui | Kakiu Ho | Anthony T. C. Chan
[1] S. Cheng,et al. An RNA-directed nucleoside anti-metabolite, 1-(3-C-ethynyl-beta-d-ribo-pentofuranosyl)cytosine (ECyd), elicits antitumor effect via TP53-induced Glycolysis and Apoptosis Regulator (TIGAR) downregulation. , 2010, Biochemical pharmacology.
[2] S. Tsao,et al. A small molecule inhibitor of NF-kappaB, dehydroxymethylepoxyquinomicin (DHMEQ), suppresses growth and invasion of nasopharyngeal carcinoma (NPC) cells. , 2010, Cancer letters.
[3] S. Tsao,et al. Cucurbitacin I elicits anoikis sensitization, inhibits cellular invasion and in vivo tumor formation ability of nasopharyngeal carcinoma cells. , 2009, Carcinogenesis.
[4] J. Grandis,et al. STAT3 activation contributes directly to Epstein‐Barr virus–mediated invasiveness of nasopharyngeal cancer cells in vitro , 2009, International journal of cancer.
[5] D. Silverman,et al. Cancer of the Pancreas , 2009 .
[6] M. Saegusa,et al. EGFR genetic heterogeneity of nonsmall cell lung cancers contributing to acquired gefitinib resistance , 2008, International journal of cancer.
[7] J. Inazawa,et al. Frequent silencing of a putative tumor suppressor gene melatonin receptor 1 A (MTNR1A) in oral squamous‐cell carcinoma , 2008, Cancer science.
[8] L. Trusolino,et al. Drug development of MET inhibitors: targeting oncogene addiction and expedience , 2008, Nature Reviews Drug Discovery.
[9] B. Foveau,et al. The shadow of death on the MET tyrosine kinase receptor , 2008, Cell Death and Differentiation.
[10] K. Rex,et al. c-Met Inhibitors with Novel Binding Mode Show Activity against Several Hereditary Papillary Renal Cell Carcinoma-related Mutations* , 2008, Journal of Biological Chemistry.
[11] S. Ishikawa,et al. Constitutive activation of c‐Met is correlated with c‐Met overexpression and dependent on cell–matrix adhesion in lung adenocarcinoma cell lines , 2007, Cancer science.
[12] R. Salgia,et al. Downstream signalling and specific inhibition of c-MET/HGF pathway in small cell lung cancer: implications for tumour invasion , 2007, British Journal of Cancer.
[13] J. Grandis,et al. Antiproliferative Mechanisms of a Transcription Factor Decoy Targeting Signal Transducer and Activator of Transcription (STAT) 3: The Role of STAT1 , 2007, Molecular Pharmacology.
[14] J. Fraumeni,et al. Cancer epidemiology and prevention. , 2006 .
[15] Eyal Gottlieb,et al. TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis , 2006, Cell.
[16] G. Mills,et al. Phosphorylation of TNF-alpha converting enzyme by gastrin-releasing peptide induces amphiregulin release and EGF receptor activation. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[17] J. Siegfried,et al. Inhibition of human non-small cell lung tumors by a c-Met antisense/U6 expression plasmid strategy , 2004, Gene Therapy.
[18] Jian-Min Yuan,et al. Epidemiology of nasopharyngeal carcinoma. , 2002, Seminars in cancer biology.
[19] B. Teh,et al. Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma. , 2002, Cancer research.
[20] T. Yoshizaki,et al. Induction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma. , 2001, The American journal of pathology.
[21] L. Ferrell,et al. Activation of the Met Receptor by Cell Attachment Induces and Sustains Hepatocellular Carcinomas in Transgenic Mice , 2001, The Journal of cell biology.
[22] C. Cooper,et al. Molecular cloning of a new transforming gene from a chemically transformed human cell line , 1984, Nature.
[23] J. Knowelden,et al. Cancer Epidemiology and Prevention , 1976, British Journal of Cancer.